Treating HIV Patients' Precancerous Growths Reduces Anal Cancer by Half
|
In
a phase 3 trial, if HIV patients received treatment for precancerous
HSILs, their risk for developing anal cancer was reduced by half. |
Indigenous organization asking feds for $20 million to help control HIV crisis
Data from the Public Health Agency of Canada found that Saskatchewan and Manitoba had the highest rate of newly diagnosed HIV cases in 2022 — 19 ... View article...